We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STRR:NASDAQStar Equity Holdings, Inc. Analysis

Data as of 2026-08-08 - not real-time

$11.30

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At $11.30, Star Equity Holdings, Inc. shows no decisive moving-average alignment, leaving the trend neutral. It has gained 4.1% over the past 30 days. Momentum indicators put RSI at 55.2 (neutral) with MACD reading bullish. The recent range runs from support at $10.23 up to resistance at $11.65.
On valuation the read is undervalued — earnings multiple of 9.2 versus a 30.7 sector average, below the peer group. Analyst price targets sit 62.2% above the current price. Revenue is growing at 57.1% on a -4.2% profit margin.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 35.0%, a beta of 0.38 and a maximum drawdown of 21.7%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 4 out of 10.

Top Market Events

Star Equity Holdings Inc STRR reports a 57% revenue increase, while navigating talent shortages and project delays.OLD GREENWICH, Conn., Aug. 07, 2026 GLOBE NEWSWIRE -- Star Equity Holdings, Inc. Nasdaq: STRR and STRRP "Star" or the...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 10.44
  • MACD momentum is positive
  • Thin trading liquidity raises execution risk

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 9.2 versus sector average of 30.7
  • Trading above the 200-day average of 10.44
  • Analyst targets imply +62.2% versus the current price

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 9.2 versus sector average of 30.7
  • Negative profit margin of -4.2%
  • Analyst targets imply +62.2% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth57.10%
Profit Margin-4.18%
P/E Ratio9.2
ROE-15.83%
ROA-2.13%
Debt/Equity43.85
P/B Ratio0.7
Op. Cash Flow$-7849000
Free Cash Flow$-13630750
Industry P/E30.7

Technical Analysis

TrendNeutral
RSI55.2
Support$10.23
Resistance$11.65
MA 20$11.03
MA 50$11.12
MA 200$10.44
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Target Price$18.33
Upside/Downside62.24%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.38
Volatility35.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.